135 related articles for article (PubMed ID: 34235809)
41. NRF2, p53, and p16: Predictive biomarkers to stratify human papillomavirus associated head and neck cancer patients for de-escalation of cancer therapy.
Ramesh PS; Devegowda D; Singh A; Thimmulappa RK
Crit Rev Oncol Hematol; 2020 Apr; 148():102885. PubMed ID: 32062315
[TBL] [Abstract][Full Text] [Related]
42. Hypofractionated Radiotherapy Upregulates Several Immune Checkpoint Molecules in Head and Neck Squamous Cell Carcinoma Cells Independently of the HPV Status While ICOS-L Is Upregulated Only on HPV-Positive Cells.
Wimmer S; Deloch L; Hader M; Derer A; Grottker F; Weissmann T; Hecht M; Gostian AO; Fietkau R; Frey B; Gaipl US
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502022
[TBL] [Abstract][Full Text] [Related]
43. PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas.
Riva G; Pecorari G; Biolatti M; Pautasso S; Lo Cigno I; Garzaro M; Dell'Oste V; Landolfo S
Mol Biol Rep; 2019 Jun; 46(3):3333-3347. PubMed ID: 30980272
[TBL] [Abstract][Full Text] [Related]
44. Influence of the human papillomavirus on the radio-responsiveness of cancer stem cells in head and neck cancers.
Reid P; Staudacher AH; Marcu LG; Olver I; Moghaddasi L; Brown MP; Bezak E
Sci Rep; 2020 Feb; 10(1):2716. PubMed ID: 32066820
[TBL] [Abstract][Full Text] [Related]
45. Human Papillomavirus Status and the Risk of Cerebrovascular Events Following Radiation Therapy for Head and Neck Cancer.
Addison D; Seidelmann SB; Janjua SA; Emami H; Staziaki PV; Hallett TR; Szilveszter B; Lu MT; Cambria RP; Hoffmann U; Chan AW; Wirth LJ; Neilan TG
J Am Heart Assoc; 2017 Aug; 6(9):. PubMed ID: 28855164
[TBL] [Abstract][Full Text] [Related]
46. Effect of radiation on cell proliferation and tumor hypoxia in HPV-positive head and neck cancer in vivo models.
Sørensen BS; Busk M; Horsman MR; Alsner J; Overgaard J; Kyle AH; Minchinton AI
Anticancer Res; 2014 Nov; 34(11):6297-304. PubMed ID: 25368228
[TBL] [Abstract][Full Text] [Related]
47. Association of human papillomavirus integration with better patient outcomes in oropharyngeal squamous cell carcinoma.
Pinatti LM; Sinha HN; Brummel CV; Goudsmit CM; Geddes TJ; Wilson GD; Akervall JA; Brenner CJ; Walline HM; Carey TE
Head Neck; 2021 Feb; 43(2):544-557. PubMed ID: 33073473
[TBL] [Abstract][Full Text] [Related]
48. A Lack of Effectiveness in the ATM-Orchestrated DNA Damage Response Contributes to the DNA Repair Defect of HPV-Positive Head and Neck Cancer Cells.
Köcher S; Zech HB; Krug L; Gatzemeier F; Christiansen S; Meyer F; Rietow R; Struve N; Mansour WY; Kriegs M; Petersen C; Betz C; Rothkamm K; Rieckmann T
Front Oncol; 2022; 12():765968. PubMed ID: 35719921
[TBL] [Abstract][Full Text] [Related]
49. HPV-positive HNSCC cell lines show strongly enhanced radiosensitivity after photon but not after carbon ion irradiation.
Lerch S; Berthold S; Ziemann F; Dreffke K; Subtil FSB; Senger Y; Jensen A; Engenhart-Cabillic R; Dikomey E; Wittig A; Eberle F; Schötz U
Radiother Oncol; 2020 Oct; 151():134-140. PubMed ID: 32717362
[TBL] [Abstract][Full Text] [Related]
50. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
[TBL] [Abstract][Full Text] [Related]
51. The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma.
Sano D; Oridate N
Int J Clin Oncol; 2016 Oct; 21(5):819-826. PubMed ID: 27339270
[TBL] [Abstract][Full Text] [Related]
52. Human papillomavirus type 16 E7 oncoprotein causes a delay in repair of DNA damage.
Park JW; Nickel KP; Torres AD; Lee D; Lambert PF; Kimple RJ
Radiother Oncol; 2014 Dec; 113(3):337-44. PubMed ID: 25216575
[TBL] [Abstract][Full Text] [Related]
53. Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation.
Liu C; Sadat SH; Ebisumoto K; Sakai A; Panuganti BA; Ren S; Goto Y; Haft S; Fukusumi T; Ando M; Saito Y; Guo T; Tamayo P; Yeerna H; Kim W; Hubbard J; Sharabi AB; Gutkind JS; Califano JA
Clin Cancer Res; 2020 Jun; 26(11):2693-2703. PubMed ID: 31932491
[TBL] [Abstract][Full Text] [Related]
54. Human papillomavirus status in young patients with head and neck squamous cell carcinoma.
van Monsjou HS; van Velthuysen ML; van den Brekel MW; Jordanova ES; Melief CJ; Balm AJ
Int J Cancer; 2012 Apr; 130(8):1806-12. PubMed ID: 21607949
[TBL] [Abstract][Full Text] [Related]
55. Human papillomavirus and gene mutations in head and neck squamous carcinomas.
Friedland P; Thomas A; Naran A; Amanuel B; Grieu-Iacopetta F; Carrello A; Harnett G; Meyer C; Phillips M
ANZ J Surg; 2012 May; 82(5):362-6. PubMed ID: 22507644
[TBL] [Abstract][Full Text] [Related]
56. pRb and CyclinD1 Complement p16 as Immunohistochemical Surrogate Markers of HPV Infection in Head and Neck Cancer.
Dreyer JH; Hauck F; Barros MHM; Niedobitek G
Appl Immunohistochem Mol Morphol; 2017; 25(5):366-373. PubMed ID: 26657876
[TBL] [Abstract][Full Text] [Related]
57. HPV-negative and HPV-positive HNSCC cell lines show similar numerical but different structural chromosomal aberrations.
Arenz A; Patze J; Kornmann E; Wilhelm J; Ziemann F; Wagner S; Wittig A; Schoetz U; Engenhart-Cabillic R; Dikomey E; Fritz B
Head Neck; 2019 Nov; 41(11):3869-3879. PubMed ID: 31441163
[TBL] [Abstract][Full Text] [Related]
58. Effect of HPV on tumor expression levels of the most commonly used markers in HNSCC.
Polanska H; Heger Z; Gumulec J; Raudenska M; Svobodova M; Balvan J; Fojtu M; Binkova H; Horakova Z; Kostrica R; Adam V; Kizek R; Masarik M
Tumour Biol; 2016 Jun; 37(6):7193-201. PubMed ID: 26666815
[TBL] [Abstract][Full Text] [Related]
59. HPV genotypes and their prognostic significance in head and neck squamous cell carcinomas.
Rautava J; Kuuskoski J; Syrjänen K; Grenman R; Syrjänen S
J Clin Virol; 2012 Feb; 53(2):116-20. PubMed ID: 22177275
[TBL] [Abstract][Full Text] [Related]
60. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
